Newsroom | CannaPharma

top of page

Gazeteler

Oct. 14, 2020

Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics

Oct. 14, 2020

The psychedelics drug market is expected to total approximately $6.8 billion by 2027.

Oct. 19, 2020

Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO

Jul. 11 2020

Companies like Growpacker have seen the potential of combining automated solutions with manual processing, and such companies will become key players in the growth of the cannabis industry.

Dec. 07 2020

Billionaire Investors Are Investing Heavily in the Psychedelics Boom

Oct. 20, 2020

Cybin Corp: Canada's Largest Go-Public Financing In The Psychedelics Sector

Dec. 12 2019

A Diamond in The Rough -- Growpacker’s Impressive Growth in The Cannabis Industry

Nov. 11 2020

Reflections of US Elections in the market

Nov. 11 2020

Cybin Inc., a Canadian pharmaceutical development startup focused on psychedelic drugs, went public on the NEO Exchange in Toronto on Monday through a reverse takeover. Cybin’s stock jumped 23% during the first two days of trading.

Feb. 11 2020

Vertically integrated business models are already lapping up customers. Models like Growpacker enable brands to go from concept to dispensary shelf with minimal overhead costs.

Sep. 24 2020

First psychedelic company to IPO on NASDQ: Compass Pathways IPO Brings $1 Billion Valuation

Jun. 10 2020

The future has never been greener for Jamaican cannabis

Jul. 16 2020

Jamaica Unveils New Cannabis Standards, With an Eye Toward the Global Industry

Dec. 16 2020

Ganja exporter with former heads of police and customs ships to Canada

Dec. 10 2019

Global Canna Labs exports from Jamaica to Canada

Dec. 27, 2020

All in all, no other country offers the same package to fuel CannaPharma’s aspirations. In one year, CannaPharma has reached a valuation of $37 million (all figures U.S.) and attracted venture capital funds and individual investors from the Netherlands and Turkey, Altug said.

Dec. 29, 2020

CannaPharma Inc., for example, whose founders’ native Turkey strictly limits marijuana use, is growing through acquisitions and ventures in the U.S., Jamaica, Portugal and Abu Dhabi. “We want to grow in everything cannabis,” Altug said in an interview.

Oct. 09, 2020

Psilocybin-assisted psychotherapy is currently being widely studied as a treatment for a range of mental health conditions including depression, anxiety, and substance use disorders. Simultaneously, Cybin is structuring and supporting clinical studies across North America and other regions, through strategic academic and institutional partnerships.

Aug. 30 2018

LGC Capital's leading Jamaican Medical Cannabis Company, Global Canna Labs, to plant 220,000 square feet of "premium" Jamaican cannabis over the next 6 weeks and also announces formal Jamaican deal closing

bottom of page